← All Sponsors
SPONSOR

Coordination Pharmaceuticals, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Head Neck CancerIntratumoral Injection
NCT05838729 Phase 1, Phase 2
Recruiting

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

Head Neck Cancer
United States View Trial →